These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Formation of eLiposomes as a drug delivery vehicle. Lattin JR; Belnap DM; Pitt WG Colloids Surf B Biointerfaces; 2012 Jan; 89():93-100. PubMed ID: 21962853 [TBL] [Abstract][Full Text] [Related]
5. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery. Javadi M; Pitt WG; Belnap DM; Tsosie NH; Hartley JM Langmuir; 2012 Oct; 28(41):14720-9. PubMed ID: 22989347 [TBL] [Abstract][Full Text] [Related]
6. Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes. Zafar MN; Abuwatfa WH; Husseini GA Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839744 [TBL] [Abstract][Full Text] [Related]
7. Investigating the Stability of eLiposomes at Elevated Temperatures. Husseini GA; Pitt WG; Javadi M Technol Cancer Res Treat; 2015 Aug; 14(4):379-82. PubMed ID: 25261070 [TBL] [Abstract][Full Text] [Related]
8. Ultrasonic gene and drug delivery using eLiposomes. Javadi M; Pitt WG; Tracy CM; Barrow JR; Willardson BM; Hartley JM; Tsosie NH J Control Release; 2013 Apr; 167(1):92-100. PubMed ID: 23352908 [TBL] [Abstract][Full Text] [Related]
9. Cytosolic delivery via escape from the endosome using emulsion droplets and ultrasound. Lattin JR; Javadi M; McRae M; Pitt WG J Drug Target; 2015 Jun; 23(5):469-79. PubMed ID: 25673266 [TBL] [Abstract][Full Text] [Related]
10. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867 [TBL] [Abstract][Full Text] [Related]
11. Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes. Awad NS; Paul V; AlSawaftah NM; Husseini GA Sci Rep; 2023 Oct; 13(1):16644. PubMed ID: 37789072 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound-triggered herceptin liposomes for breast cancer therapy. Elamir A; Ajith S; Sawaftah NA; Abuwatfa W; Mukhopadhyay D; Paul V; Al-Sayah MH; Awad N; Husseini GA Sci Rep; 2021 Apr; 11(1):7545. PubMed ID: 33824356 [TBL] [Abstract][Full Text] [Related]
13. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes. Kullberg M; Owens JL; Mann K J Drug Target; 2010 May; 18(4):313-20. PubMed ID: 20201742 [TBL] [Abstract][Full Text] [Related]
14. Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes. Awad NS; Paul V; Mahmoud MS; Al Sawaftah NM; Kawak PS; Al Sayah MH; Husseini GA ACS Biomater Sci Eng; 2020 Jan; 6(1):48-57. PubMed ID: 33463192 [TBL] [Abstract][Full Text] [Related]
15. Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound. Ben Daya SM; Paul V; Awad NS; Al Sawaftah NM; Al Sayah MH; Husseini GA J Biomed Nanotechnol; 2021 Jan; 17(1):90-99. PubMed ID: 33653499 [TBL] [Abstract][Full Text] [Related]
17. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy. Awad NS; Paul V; Al-Sayah MH; Husseini GA Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869 [TBL] [Abstract][Full Text] [Related]
18. Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells. Shin JH; Shin DH; Kim JS Asian J Pharm Sci; 2020 Jul; 15(4):472-481. PubMed ID: 32952670 [TBL] [Abstract][Full Text] [Related]
19. Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy. Lin CY; Javadi M; Belnap DM; Barrow JR; Pitt WG Nanomedicine; 2014 Jan; 10(1):67-76. PubMed ID: 23845926 [TBL] [Abstract][Full Text] [Related]
20. Future directions of liposome- and immunoliposome-based cancer therapeutics. Park JW; Benz CC; Martin FJ Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]